Log In
Print this Print this

Opegan, sodium hyaluronate

  Manage Alerts
Collapse Summary General Information
Company Seikagaku Corp.
DescriptionHyaluronic acid formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsUsed during ophthalmic surgery
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today